Rapid on‐site evaluation (ROSE) can increase adequacy and reduce needle passes in fine‐needle aspiration cytology (FNAC) procedures. However, ROSE increases the cost of FNAC. Costs may be reduced if ROSE… Click to show full abstract
Rapid on‐site evaluation (ROSE) can increase adequacy and reduce needle passes in fine‐needle aspiration cytology (FNAC) procedures. However, ROSE increases the cost of FNAC. Costs may be reduced if ROSE is performed by an alternate evaluator (AE), such as a cytotechnologist (CT), endoscopist, or pulmonologist, rather than a cytopathologist (CP). Studies have shown that AEs can perform ROSE with high accuracy but are generally not as accurate as CPs. The objective of this study was to evaluate the impact of AEs on the cost‐effectiveness of ROSE.
               
Click one of the above tabs to view related content.